Date: This live activity will take place on February 5, 2019 from 1:00 pm – 2:00 pm ET. Participants must attend this live activity in its entirety to receive credit.

*Per ACPE, this live activity must be completed by April 6, 2019 at 11:59 pm ET. No exceptions or extensions permitted. *

Cost: Free for ASCP Members, $10 for Non-Members. Can't make the live program, the on-demand version will available to ASCP learners and posted on March 1, 2019 for 6-months.

*If you are looking for BCGP registration, please click here**

To Purchase: Make sure you are signed into you ASCP account. For paid courses, click “Buy-Now” and complete the checkout process. For free courses, click “Launch”. This course will now be listed in your “My Learning” tab inside “Active”.

To Pre-register: Launch the course. In the pop-up window, click the registration on the left. It may take 3-5 seconds to load. When successful, you will see a dialog for when the webinar will start and shortly receive an email confirmation. Check your SPAM folder if you do not receive the link to your email. You can also return to this course on the day of the registration and "Launch" the activity from here.

To Join Webinar: Launch the course. In the pop-up window, click the registration on the left. It may take 3-5 seconds to load. When successful, you should receive a download for GoToWebinar to start the webinar. Alternatively, you can also join the webinar from the email reminders or confirmation you should have received if you preregistered. To join from a mobile device, you should follow the “Join Webinar” link from the email reminders or confirmation. You may be asked to install an app to join the webinar.

Speaker:
Elizabeth Pogge, PharmD, MPH, BCPS-AQ Cardiology, FASCP, FAzPA
Associate Professor
Midwestern University College of Pharmacy - Glendale

Financial Disclosure:
The speaker discloses no relevant financial conflicts of interest with regard to this activity.

Target Audience:
Chronic heart failure is a common diagnosis that affects older adults. This interactive, case based session, will review the current guideline-directed medical therapy for patients with heart failure with reduced (HFrEF) and preserved (HFpEF) ejection fraction. The session will include a discussion of two newer agents for the treatment of HFrEF, sacubitril/valsartan and ivabradine, with an emphasis on appropriate utilization and monitoring in older adults.

Learning Objectives:
At the conclusion of this Application-Based activity, participants should be able to:

• Explain the pathophysiology behind the development of chronic heart failure.
• List lifestyle changes used in the treatment of chronic heart failure.
• Describe current guideline-directed medical therapy for patients with chronic heart failure, including the place in therapy of sacubitril/valsartan and ivabradine.
• Apply the principals of pharmacotherapy for chronic heart failure to patient cases.

*A recorded version will be posted by March 1, 2019 with UAN: 0203-0000-19-013-H01-P

*This activity is NOT FL Consultant Approved

How to Earn Credit:
Post-Test: You will have unlimited attempts to achieve a 70% or higher on the post-test assessment.

CPE Credit: You must complete the post-test and evaluation by April 6, 2019 at 11:59 pm ET to receive credit. ASCP reports CPE attainment to ACPE and NABP via the CPE Monitor system. The course should be posted within 24-48 hours of evaluation completion. It is the responsibility of the participant to provide their correct date of birth (MMDD format) and NABP e-Profile ID on their member or guest profile on the ASCP Website.

Please see computer hardware/software requirements here.